On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist … ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

A Wegovy pill is now available in pharmacies nationwide. The weight loss medication is an alternative to GLP-1 injections. Below, a weight loss expert shares what you need to know. Wegovy—a medication ...

The Wegovy pill launched Monday, and the starting dose is now available at pharmacies around the country with higher doses arriving by the end of the week. The Food and Drug Administration approved ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic and Wegovy, is now the first company to manufacture and receive FDA ...

They’re the seemingly miraculous solution to weight loss, helping people shed stubborn pounds that other diet and food ...